This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Merck & Co Inc (MRK)

NYSE: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 39.50B 42.24B 44.03B 47.27B
Cost of Sales 14.93B 10.08B 9.97B 9.47B
Gross Operating Profit 24.56B 32.16B 34.07B 37.80B
Selling, General, and Administrative Expenses 10.31B 11.61B 11.91B 12.78B
Research & Development 6.70B 7.18B 7.50B 8.17B
Operating Income before D & A (EBITDA) 7.55B 13.37B 14.65B 16.86B
Depreciation & Amortization n.a. 6.69B 6.99B 6.98B
Interest Income n.a. 266.00M 264.00M 232.00M
Other Income - Net -1.53B 11.82B -278.00M -634.00M
Special Income / Charges 0.00 0.00 404.00M 642.00M
Total Income Before Interest Expenses (EBIT) 5.40B 18.02B 6.35B 9.45B
Interest Expense 0.00 732.00M 801.00M 714.00M
Pre-Tax Income 5.40B 17.28B 5.54B 8.74B
Income Taxes 942.00M 5.35B 1.03B 2.44B
Minority Interest 17.00M 14.00M 113.00M 131.00M
Net Income From Continuing Operations 4.46B 11.93B 4.52B 6.30B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 4.46B 11.93B 4.52B 6.30B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 4.44B 11.92B 4.40B 6.17B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
5.08B 12.95B 5.82B 6.32B
Preferred Dividends
Net Income Available To Common 0.00 11.93B 4.52B 6.30B
Basic EPS from Continuing Ops. 1.59 4.12 1.49 2.03
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.59 4.12 1.49 2.03
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.59 4.12 1.49 2.03
Basic Normalized Net Income/Share 1.81 4.47 1.92 2.03
EPS fr Continuing Ops. 1.56 4.07 1.47 2.00
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.56 4.07 1.47 2.00
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.56 4.07 1.47 2.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.78 4.42 1.89 2.01
Dividends Paid per Share 1.81 1.77 1.73 1.69
MRK News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for MRK

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 8 8 7
Moderate Buy 0 0 0 0
Hold 7 6 6 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET MRK ANALYST REPORT

MRK Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs